Literature DB >> 11232460

[Endoscopic diagnosis of a gastric heterotopic pancreas and esophageal atresia: an incidental association?].

G Pouessel1, L Michaud, M H Pierre, D Guimber, R Sfeir, Y Robert, F Gottrand, D Turck.   

Abstract

UNLABELLED: Heterotopic or aberrant pancreas is a rare congenital anomaly, usually asymptomatic. The preoperative diagnosis is difficult but most cases of gastric ectopic pancreas have a unique appearance that often makes possible a diagnosis in the absence of histologic confirmation. A well-delineated submucosal, firm mass with central umbilication is characteristic of gastric ectopic pancreas. To the best of our knowledge, the association of esophageal atresia and gastric heterotopic pancreas has never been reported previously. CASE REPORTS: We report two cases of heterotropic pancreas associated with esophageal atresia. Both diagnoses were incidental findings and concerned children operated on at birth for esophageal atresia. Although a definitive diagnosis is histologic, the endoscopic appearance made it possible to maintain this diagnosis.
CONCLUSION: Some symptoms have been attributed to ectopic pancreas, and malignant degeneration has been reported in adults. Management continues to be debated: some authors recommend surgical resection while others, as we do, prefer initial therapeutic abstention.

Entities:  

Mesh:

Year:  2001        PMID: 11232460     DOI: 10.1016/s0929-693x(00)00182-2

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

2.  Diagnosis and treatment of gastric heterotopic pancreas.

Authors:  Orri Thor Ormarsson; Ingibjorg Gudmundsdottir; Ronald Mårvik
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

Review 3.  Present status and perspectives of endosonography 2017 in gastroenterology.

Authors:  Michael Hocke; Barbara Braden; Christian Jenssen; Christoph F Dietrich
Journal:  Korean J Intern Med       Date:  2017-11-23       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.